Clinical Trials · NCT05590793

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ipsen
Enrollment
195
Start date
Nov 2022
Locations
36 sites, China
Primary endpoint
Percentage of Participants Who Achieved Castrate Levels of Serum Testosterone on Day 29
View Gonadorelin compound reference